NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 4 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Chaidez, Virginia; Hansen, Robin L.; Hertz-Picciotto, Irva – Journal of Autism and Developmental Disorders, 2014
To compare gastrointestinal (GI) problems among children with: (1) autism spectrum disorder (ASD), (2) developmental delay (DD) and (3) typical development (TD), GI symptom frequencies were obtained for 960 children from the CHildhood Autism Risks from Genetics and Environment (CHARGE) study. We also examined scores on five Aberrant Behavior…
Descriptors: Children, Autism, Pervasive Developmental Disorders, Developmental Delays
Peer reviewed Peer reviewed
Direct linkDirect link
Braunschweig, Daniel; Duncanson, Paul; Boyce, Robert; Hansen, Robin; Ashwood, Paul; Pessah, Isaac N.; Hertz-Picciotto, Irva; Van de Water, Judy – Journal of Autism and Developmental Disorders, 2012
Autism spectrum disorders (ASDs) affect approximately 1 in 110 children in the United States. This report profiles fetal-brain reactive autoantibodies of a large cohort of mothers of children with autism and controls, yielding significant associations between the presence of IgG reactivity to fetal brain proteins at 37 and 73 kDa and a childhood…
Descriptors: Mothers, Autism, Disability Identification, Children
Peer reviewed Peer reviewed
Direct linkDirect link
Bent, Stephen; Bertoglio, Kiah; Ashwood, Paul; Bostrom, Alan; Hendren, Robert L. – Journal of Autism and Developmental Disorders, 2011
We conducted a pilot randomized controlled trial to determine the feasibility and initial safety and efficacy of omega-3 fatty acids (1.3 g/day) for the treatment of hyperactivity in 27 children ages 3-8 with autism spectrum disorder (ASD). After 12 weeks, hyperactivity, as measured by the Aberrant Behavior Checklist, improved 2.7 (plus or minus…
Descriptors: Autism, Hyperactivity, Food, Pervasive Developmental Disorders
Peer reviewed Peer reviewed
Direct linkDirect link
Pandina, Gahan J.; Bossie, Cynthia A.; Youssef, Eriene; Zhu, Young; Dunbar, Fiona – Journal of Autism and Developmental Disorders, 2007
Subgroup analysis of children (5-12 years) with autism enrolled in an 8-week, double-blind, placebo-controlled trial of risperidone for pervasive developmental disorders. The primary efficacy measure was the Aberrant Behavior Checklist-Irritability (ABC-I) subscale. Data were available for 55 children given risperidone (n = 27) or placebo (n =…
Descriptors: Autism, Drug Therapy, Children, Behavior Modification